Literature DB >> 7913749

CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.

J Ennen1, H Findeklee, M T Dittmar, S Norley, M Ernst, R Kurth.   

Abstract

Following natural and experimental infection by simian immunodeficiency virus SIVagm of African green monkeys (AGMs), the natural host, there is no evidence for the development of an immunodeficiency. Within the framework of our studies on human immunodeficiency virus (HIV)/SIV pathogenesis, we investigated the influence of CD8 T lymphocytes on SIVagm replication in AGM CD4 T lymphocytes in vitro. The following observations were made: (i) Peripheral blood mononuclear cells from both seronegative and seropositive AGMs contained only a low proportion (i.e., 10%) of CD4+ lymphocytes, whereas a high proportion (80%) of CD8+ cells was detected. Even after persistent SIVagm infection, CD4 T lymphocytes do not decrease in number. (ii) The target of in vitro infection of peripheral blood cells is the CD4+ mononuclear cell (T lymphocytes, monocytes) and SIVagm infects by binding to the CD4 molecule. (iii) In both naturally and experimentally SIVagm-infected AGMs the CD4+ T cells and monocytes, but not the CD8+ T cells, harbor DNA provirus. (iv) Virus reisolation and virus replication of SIVagm in CD4 T lymphocytes from seropositive AGMs is suppressed in the presence of autologous CD8 T lymphocytes or a soluble factor produced by these cells. Taken together, one possible reason for the apathogenicity of the SIVagm infection in AGMs may be the suppression of virus replication by a soluble, yet unidentified factor secreted by CD8 lymphocytes quantitatively dominating among peripheral blood cell populations. We have tentatively termed this factor "immunodeficiency virus-suppressing lymphokine." In addition, we show that immunodeficiency virus-suppressing lymphokine from AGMs is able to suppress HIV-1 replication in human CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913749      PMCID: PMC44368          DOI: 10.1073/pnas.91.15.7207

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates.

Authors:  Y Ohta; T Masuda; H Tsujimoto; K Ishikawa; T Kodama; S Morikawa; M Nakai; S Honjo; M Hayami
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

2.  Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes.

Authors:  M Kannagi; L V Chalifoux; C I Lord; N L Letvin
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

Review 3.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

4.  CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses.

Authors:  C M Walker; G A Thomson-Honnebier; F C Hsueh; A L Erickson; L Z Pan; J A Levy
Journal:  Cell Immunol       Date:  1991-10-15       Impact factor: 4.868

5.  Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees.

Authors:  B A Castro; C M Walker; J W Eichberg; J A Levy
Journal:  Cell Immunol       Date:  1991-01       Impact factor: 4.868

6.  Mutational analysis of the simian immunodeficiency virus SIVmac nef gene.

Authors:  D Binninger; J Ennen; D Bonn; S G Norley; R Kurth
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection.

Authors:  J E Brinchmann; J Albert; F Vartdal
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  Simian immunodeficiency virus from African green monkeys.

Authors:  M D Daniel; Y Li; Y M Naidu; P J Durda; D K Schmidt; C D Troup; D P Silva; J J MacKey; H W Kestler; P K Sehgal
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Functional analysis of monkey lymphocyte subsets defined by OKT4 and OKT8 Monoclonal Antibodies.

Authors:  L N Martin; B J Gormus; B E Bozelka
Journal:  Cell Immunol       Date:  1983-04-15       Impact factor: 4.868

10.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

View more
  18 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 2.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor.

Authors:  M Baier; N Bannert; A Werner; K Lang; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.

Authors:  I S Choi; R Hokanson; E W Collisson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys.

Authors:  O M Diop; A Gueye; M Dias-Tavares; C Kornfeld; A Faye; P Ave; M Huerre; S Corbet; F Barre-Sinoussi; M C Müller-Trutwin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus).

Authors:  V Jubier-Maurin; P Sarni-Manchado; F Veas; N Vidal; F Bibollet-Ruche; J P Durand; A Galat-Luong; G Cuny
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm.

Authors:  Roland C Zahn; Melisa D Rett; Birgit Korioth-Schmitz; Yue Sun; Adam P Buzby; Simoy Goldstein; Charles R Brown; Russell A Byrum; Gordon J Freeman; Norman L Letvin; Vanessa M Hirsch; Jörn E Schmitz
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx).

Authors:  Richard Onanga; Sandrine Souquière; Maria Makuwa; Augustin Mouinga-Ondeme; François Simon; Cristian Apetrei; Pierre Roques
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.